Delivery Order SPE2DB24D1034-SPE2DB25FWAD1

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS with a ceiling value of $39,224.84 and a completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a specialty medication, with a ceiling value of $11,593.65. The contract does not have a set-aside designation and has a period of performance through September 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty pharmaceutical product. The contract has a firm fixed price of $6,560.58 and a completion date of August 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This is a firm fixed-price delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,065.83, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $18,448.25 and runs through January 29, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA worth...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a ceiling value of $37,397.12 and a period of performance through January 8, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, a specialty medication used for various medical treatments. The contract is a firm fixed-price delivery order with a ceiling value of $23,107.76 and a period of performance through January 16, 2025. This contract award is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,483,603 units of the biologic medication CIMZIA 2X200 MG/ML syringe kits. The contract has a ceiling value of $3,280.28 and a completion date of August 19, 2024. It is a firm fixed-price contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will deliver these critical medical supplies to support military...
The U.S. government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CIMZIA 2X200 MG/ML Syringe Kits. The contract has a Firm Fixed Price pricing type and a ceiling value of $4,275.48. The ultimate completion date is January 16, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the Defense Logistics Agency (DLA) Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a ceiling value of $38,303.44 and a period of performance through January 15, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAD1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a ceiling value of $6,184.48 and a completion date of January 30, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/30/25, 9:53 AM